A study using an app to help people having treatment for neuroendocrine tumours

Cancer type:

Neuroendocrine tumour (NET)

Status:

Open

Phase:

Other

This study is looking at a mobile application (app) for people to report their symptoms and how they are feeling during treatment.

More about this trial

Researchers have developed an app for people having treatment for neuroendocrine tumours.

The purpose of this app is to help people during their treatment. It allows them to report symptoms to their hospital team. And it allows the hospital team to record how people are feeling and if there are any changes in their quality of life following treatment.

You use the mobile application to:

  • report any symptoms you are having 
  • report side effects of treatment 
  • report how you’ve been feeling (quality of life Open a glossary item)
  • keep a record of hospital appointments

The information in the app is analysed. The healthcare team can see your answers on the system. If necessary, they can message you through the app or contact you via email or phone. The app also provides links to online resources for education and support.

The main aims of the study are to:

  • check if it’s possible to monitor symptoms via the app
  • see if people think the app is useful 
  • see if people use it to complete the quality of life questionnaires

Who can enter

The following bullet points are a summary of the entry conditions for this study. Talk to your doctor or the study team if you are unsure about any of these. They will be able to advise you. 

Who can take part

You may be able to join this study if all of the following apply. You:

  • have a neuroendocrine tumour and are due to have treatment. The treatment may include chemotherapy, everolimus, sunitinib, somatostatin analogues, peptide receptor radionuclide therapy (PRRT), embolization treatments, ablative treatment or surgery. We have information about these treatments for NETs
  • can speak and understand English
  • are at least 18 years old 

Who can’t take part

You cannot join this study if any of these apply. You:

  • have another cancer that you are having treatment for 
  • don’t have a smartphone or tablet
  • may have problems understanding the questionnaires and how to complete them
  • have a mental health problem that the study team think could affect you taking part

Trial design

The study team need 2,000 people to take part. 

You download the application from your mobile device app store onto your phone or tablet. 

You report your symptoms on the app each day. There are daily alerts to remind you to do this. The length of time that you report these symptoms varies according to which treatment you are having. The study team can tell you more about this.

You also complete 6 quality of life questionnaires. The team may call these PROMs. This stands for patient reported outcome measures. Researchers use PROMs to assess how people are feeling, and how they rate their quality of life. You do these on the app:

  • when you join the study
  • at 1 month and then 
  • every 3 months for 1 year

Hospital visits

You don’t have any extra hospital visits if you take part in this trial.

Side effects

The researchers don’t think you will have any extra side effects if you take part in this study. However answering questions about any symptoms you may have, could cause you to think more about them.

The information you provide is stored electronically. All the information you provide is confidential Open a glossary item. It won’t be possible to identify you in any results from the study.

Location

Basingstoke
London
Manchester
Sheffield

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Dr Rajaventhan Srirajaskanthan

Supported by

King’s College Hospital NHS Foundation Trust (KCH)
Imaging Equipment Limited 
Neuroendocrine Cancer UK

Freephone 0808 800 4040

Last review date

CRUK internal database number:

17725

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Charlie took part in a trial to try new treatments

A picture of Charlie

“I think it’s really important that people keep signing up to these type of trials to push research forward.”

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think